7 months ago
EXEL
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 20%
#901 out of 4565 analysts
Average Return
+8.06%
Win Rate
50%22 out of 44
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +235.60% | $26.18 | $87.86 | 2020-04-23 - 2020-10-22 | Strong Buy |
Mirati Therapeutics IncMRTX | +182.05% | $13.20 | $37.23 | 2017-11-14 - 2018-11-14 | Buy |
Forty Seven IncFTSV | +165.60% | $35.96 | $95.51 | 2019-12-11 - 2020-04-06 | Strong Buy |
Mirati Therapeutics IncMRTX | +87.42% | $31.32 | $58.70 | 2023-07-24 - 2024-01-22 | Strong Buy |
Zentalis Pharmaceuticals IncZNTL | +67.39% | $35.57 | $59.54 | 2020-04-28 - 2021-04-28 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
9 months ago
SNDX
a year ago
BGNE
2 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $92.00 | +58.62% | Reiterates | 4 days ago |
Immunome IncIMNM | 1 | Strong Buy | $35.00 | +145.44% | Initiates Coverage On | 12 days ago |
Adc Therapeutics SaADCT | 1 | Strong Buy | $11.00 | +147.75% | Initiates Coverage On | a month ago |
Mersana Therapeutics IncMRSN | 2 | Strong Buy | $7.00 | +145.61% | Upgrades | 2 months ago |
Beigene LtdBGNE | 4 | Strong Buy | $345.00 | +132.23% | Maintains | 2 months ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | -0.74% | Downgrades | 5 months ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | +76.81% | Maintains | 6 months ago |
Exelixis IncEXEL | 3 | Strong Buy | $30.00 | +27.50% | Reiterates | 7 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $42.00 | +104.18% | Maintains | 9 months ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | +2.21% | Maintains | 9 months ago |
Adicet Bio IncACET | 3 | Hold | $20.00 | +1,004.97% | Downgrades | 10 months ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $82.00 | -9.62% | Maintains | a year ago |
Oric Pharmaceuticals IncORIC | 2 | Hold | $15.00 | N/A | Downgrades | a year ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | a year ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $22.00 | N/A | Upgrades | a year ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Upgrades | a year ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $28.00 | N/A | Maintains | a year ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Incyte CorpINCY | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Erasca IncERAS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Rain Oncology IncRAIN | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 3 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 4 years ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Bluebird Bio IncBLUE | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 5 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 6 years ago |
Array Technologies IncARRY | 1 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 6 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.